148
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A ketone-functionalized Zn-MOF for solvent-free cyanosilylation of aldehyde and treatment activity against osteosarcoma trough increasing Mg63 cells autophagy

, , , &
Pages 2235-2249 | Received 21 Apr 2020, Accepted 16 Aug 2020, Published online: 23 Sep 2020
 

Abstract

In this work, 5,5′-carbonyldiisophthalic acid (H4cipa) was used as a ligand to react with Zn(NO3)2·6H2O in a mixed solvent of DMF and water to prepare a new metal-organic framework (MOF) with the chemical formula of [Zn2(cipa)(H2O)2](DMF) (1). Due to its O donor sites within the one-dimensional channels and high density of open metal sites, the activated 1a was applied as a heterogeneous catalyst for the formation of C–C bonds of carbonyl compounds in the absence of solvents, which shows high efficiency and size-selectivity. Furthermore, the possible reaction mechanism has been proposed based on the experimental results. The treatment activity of the new compound on the Mg63 osteosarcoma cell line was evaluated and the possible mechanism was discussed. First, flow cytometry was performed to detect the levels of the Mg63 cancer cells’ autophagy levels after indicated compound treatment. Next, real time RT-PCR assay was further conducted to measure the relative expression levels of the autophagic genes under treatment.

Graphical abstract

Acknowledgements

The research did not receive any specific funding.

Disclosure statement

The authors declare there is no conflict of interest regarding the publication of this paper.

Data availability

The data used to support the findings of this study are included within the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.